Skip to content

Boston Scientific BSX Letters of Credit Outstanding, Amount

Letters of Credit Outstanding, Amount at other companies

DigitalOcean logo
DigitalOceanDOCN
0-100%
General Dynamics logo
General DynamicsGD
$2.1B0.0%
International Flavors & Fragrances logo
International Flavors & FragrancesIFF
$53M-7.0%
M&T Bank logo
M&T BankMTB
$53M0.0%
State Street logo
State StreetSTT
$461M-43.2%
Raymond James Financial logo
Raymond James FinancialRJF
$217M+95.5%

Other financials

Income statement

See full
Revenue$5.2B+11.6%
Gross profit$3.6B+12.6%
Operating income$1.1B+19.5%
Net income$1.3B+99.3%
EPS (diluted)$0.90+100%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.4%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$67.32B-37.5%
P/E18.9×-34.3×
P/S3.3×-2.9×

Profitability

See full
Gross margin69.2%+0.5pp
Operating margin18.4%+2.2pp
Net margin17.3%+5.7pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:LettersOfCreditOutstandingAmount.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's letters of credit outstanding, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Boston Scientific's letters of credit outstanding, amount?
Boston Scientific (BSX) reported letters of credit outstanding, amount of $193M in Q1 2026.
How has Boston Scientific's letters of credit outstanding, amount changed year-over-year?
Boston Scientific's letters of credit outstanding, amount decreased by 11.5% year-over-year, from $218M to $193M.
What is the long-term trend for Boston Scientific's letters of credit outstanding, amount?
Over 5 years (2020 to 2025), Boston Scientific's letters of credit outstanding, amount has grown at a 10.4% compound annual growth rate (CAGR), from $124M to $203M.